Cite
Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway.
MLA
Yu, Jie, et al. “Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway.” Mediators of Inflammation, vol. 2023, Jan. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1155/2023/8974960.
APA
Yu, J., Zhao, Y., Xu, L., Li, W., Zhang, H., Ping, F., & Li, Y. (2023). Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway. Mediators of Inflammation, 2023, 1–12. https://doi.org/10.1155/2023/8974960
Chicago
Yu, Jie, Yuan Zhao, Lingling Xu, Wei Li, Huabing Zhang, Fan Ping, and Yuxiu Li. 2023. “Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway.” Mediators of Inflammation 2023 (January): 1–12. doi:10.1155/2023/8974960.